A new startup founded on science from the labs of Massachusetts General and Brigham and Women’s Hospital is taking aim at fibrosis — and it has a veritable battalion of Big Pharma companies backing it.
Access article on bizjournals.com (paywall)
A new startup founded on science from the labs of Massachusetts General and Brigham and Women’s Hospital is taking aim at fibrosis — and it has a veritable battalion of Big Pharma companies backing it.
Access article on bizjournals.com (paywall)